Beta-2 microglobulin (B2M) handling in continuous ambulatory peritoneal dialysis (CAPD) was characterized in acute and chronic clinical studies. Average clearance rate was 0.7 mLlmin and mean mass transfer coefficient, KoA, was calculated to be 0.95 cm2lmin; these values are in the range expected from extrapolation of published data for other large solutes. In chronic studies with both anuric and oliguric populations, CAPD was shown to be much more effective than conventional hemodialysis in removing B2M and, in fact, CAPD removal rates were equivalent to those reported for high flux dialysis therapies. However, this greater extraction was not associated with any clinically significant reduction in circulating plasma concentrations. These trends remained valid in both the anuric and oliguric subsets of the study population.
KohnleW., SprengerK., SpohnB., FranzH.E.Hemodiafiltration using readily available equipment.J Dial.1979; 3: 27–39.
4.
StreicherE., SchneiderH.Mass transport in hemodiafiltration.Nieren Hochdruckkankh.1983; 12: 339–342.
5.
HirszelP., LasrichM., MaherJ.M., MaherJ.F.Prediction of solute transport during peritoneal dialysis.Artif Organs.1979; 3: 228–229.
6.
RippeB., StelinS., AhlmenJ.Basal permeability of the peritoneal membrane during continuous ambulatory peritoneal dialysis (CAPD). In: GahlG.M., KesselM., NolphK.D., eds. Advances in peritoneal dialysis.Amsterdam: Excerpta Medica; 1981: 5–9.
7.
KozjakD., PrejacM., Jeren-StruicB., GudelJ., KovarbasicB.Clearance of urea, creatinine, Beta 2 microglobulin and the loss of proteins in treatment with continuous ambulatory peritoneal dialysis.Lijec Vjesn.1982; 104: 532–535.
8.
WideroeT.E., SmebyL.C., MjalandS., DahlK., BergK.J., WesselA.T.Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.Nephron.1984; 38: 238–247.
9.
SchuppeH.C., SeidlerA., SchollmeyerP., BoeskenW.H.Peritoneal permeability for small proteins and immunoglobulins under CAPD.Protides Biol Fluids.1985; 32: 359–362.
10.
SteinhauserH.B., SchollmeyerP.Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis.Kidney Int.1986; 29: 584–590.
11.
KredietR.T., ZuyderhoudtF.M., BoeschotenE.W., AriszL.Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritonitis patients.Eur J Clin Invest.1987; 17: 43–52.
12.
GeyjoF., YamadaT., OdaniS.A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2 microglobulin.Biochem Biophys Res Commun.1985; 129: 701–706.
13.
GeyjoF., OdaniS., YamadaT.Beta 2 microglobulin: A new form of amyloid protein associated with chronic hemodialysis.Kidney Int.1986; 30: 385–390.
14.
GorevicP.D., MonozP.C., CaseyT.T.Polymerization of intact Beta 2 microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis.Proc Natl Acad Sci USA.1986; 83: 7908–7912.
15.
RitzE., BommerJ.Beta-2 microglobulin-derived amyloid problems and perspectives.Blood Purif.1988; 6: 61–68.
16.
CharraB., CalemardE., LaurantG.Chronic renal failure treatment duration and mode: Their relevance to the late dialysis periarticular syndrome.Blood Purif1988; 6: 117–124.
17.
GejyoF., HommaN., ArakawaM.Carpal Tunnel Syndrome and {12 microglobulin-related amyloidosis in chronic hemodialysis patients.Blood Purif1988; 6: 125–131.
18.
GorevicP.D., MunozP.Dialysis amyloidosis: Beta-2 microglobulin in the context of other amyloidogenic proteins.Blood Purif1988; 6: 132–144.
19.
PepysM.B.Amyloidosis: Some recent findings.Q J Med.1988; 67: 283–298.
20.
SimonP., CavarleYy, AngK.S., CamG., CathelineM.Long-term variations in serum Beta-2 Microglobulin levels in hemodialysed uremics according to permeability and bioincompatibility of dialysis membranes.Blood Purif1988; 6: 111–116.
21.
EDTA Registry report1987. Nephrol Dial Transplant. (in press).
22.
KlinkeB., RoeckelA., PerschelW., AbdelhamidS., FiegelP., WalbD.Transmembranous transport and adsorptive capacity of Beta-2 microglobulin in different hemofilters. (Abstract) Blood Purif1988; 6: 379.
23.
JorstadS., SmebyL.C., BalstadT., WidoroeT.E.Removal, generation, and adsorption of Beta-2 microglobulin during hemofiltration with five different membranes.Blood Purif1988; 6: 96–105.
SaitoA., OgawaH., OnoM.Long-term changes in serum low molecular weight proteins in CAPD patients. (Abstract) Blood Purif1988; 6: 376.
30.
BardinT., CornnelisF., KuntzD.Muscoskeletal complaints and B2 microglobulin in uremic patients treated with peritoneal dialysis. (Abstract) Arthritis Rheum.1987; 30: S84.
31.
RandersonD.H., FarrellP.C.Mass transfer properties of the human peritoneum.ASAIO J.1981; 3: 140–146.
32.
GarredL.J., CanaudB., FarrellP.C.A simple kinetic model for assessing peritoneal mass transfer in chronic ambulatory peritoneal dialysis.ASAIO J.1983; 6: 131–137.
33.
BergstromJ., We hIeB.No change in corrected {12 M concentration after Curpophane hemodialysis. (Letter) Lancet.1987; 1: 628–629.
RottembourgJ., IssadB., GallegoJ.L.Evolution of residual renal function in patients undergoing maintenance hemodialysis or continuous ambulatory peritoneal dialysis.Proc EDTA.1983; 19: 397–403.
38.
CancariniG.C., BrunoriG., CameriniC.Renal function recovery and maintenance of residual diuresis in CAPD and hemodialysis.Perit Dial Bull.1986; 6: 77–79.
